Cogentix Medical (Cogentix Medical) Total Payout Ratio : 0.00 (As of Apr. 27, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Cogentix Medical Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Cogentix Medical's current Total Payout Ratio is 0.00.

Cogentix Medical Total Payout Ratio Historical Data

The historical data trend for Cogentix Medical's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cogentix Medical Total Payout Ratio Chart

Cogentix Medical Annual Data

Trend

Mar08

Mar09

Mar10

Mar11

Mar12

Mar13

Mar14

Mar15

Dec16

Dec17

Total Payout Ratio

Get a 7-Day Free Trial

0.08

1.06

Cogentix Medical Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cogentix Medical's Total Payout Ratio

For the Medical Devices subindustry, Cogentix Medical's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cogentix Medical's Total Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cogentix Medical's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Cogentix Medical's Total Payout Ratio falls into.

Cogentix Medical Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Cogentix Medical's Total Payout Ratio for the fiscal year that ended in Dec. 2017 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-0.883
	=	0.00

Cogentix Medical's Total Payout Ratio for the quarter that ended in Dec. 2017 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	0.068
	=	0.00

Cogentix Medical Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Cogentix Medical's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Cogentix Medical (Cogentix Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cogentix Medical Inc (NAS:CGNT) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

5420 Feltl Road, Minnetonka, MN, USA, 55343

Website

http://www.cogentixmedical.com

Cogentix Medical Inc is a medical device company. The company designs, develops, manufactures and markets a robust line of high-performance fiberoptic and video endoscopy products under the PrimeSight brand that is used across multiple surgical specialties in diagnostic and treatment procedures. Cogentix offers the Urgent PC Neuromodulation System, a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). It also develops Macroplastique an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily resulting from intrinsic sphincter deficiency.

Executives

Nachum Shamir	director	12212 TECHNOLOGY BLVD, AUSTIN TX 78727
Brett Reynolds	officer: SVP, CFO, Treasurer	5000 W 36TH STREET, MINNEAPOLIS MN 55416
Kenneth A Samet	director	800 KING FARM BOULEVARD, 4TH FLOOR, ROCKVILLE MD 20850
Uri Geiger	director	221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815
Accelmed Growth Partners, L.p.	10 percent owner	6 HACHOSHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners Management Ltd.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (gp), L.p.	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Accelmed Growth Partners (agp) Ltd	10 percent owner	6 HACHOCHLIM STREET, 6TH FLOOR, HERZLIYA PITUACH L3 4672406
Cheryl Pegus	director	40 RAMLAND ROAD, ORANGEBURG CA 10962
Kenneth H Paulus	director	5420 FELTL ROAD, MINNETONKA MN 55343
Sven Wehrwein	director
Kevin H Roche	director
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010